Liver Diseases Therapeutics Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4162876
- 88 Pages
- January 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Liver Diseases Therapeutics Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Liver Diseases Therapeutics Drugs market segmented into
Oral
Injection
Based on the end-use, the global Liver Diseases Therapeutics Drugs market classified into
Hospitals
Clinics
Others
Based on geography, the global Liver Diseases Therapeutics Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Achillion Pharmaceuticals
AbbVie
Angion Biomedica
Bayer
LG Life Sciences
Phenex Pharmaceuticals
ProMetic Life Sciences
Raptor Pharmaceuticals
Shenzhen Kangtai Biological Products
Verva Pharmaceuticals
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LIVER DISEASES THERAPEUTICS DRUGS INDUSTRY
2.1 Summary about Liver Diseases Therapeutics Drugs Industry
2.2 Liver Diseases Therapeutics Drugs Market Trends
2.2.1 Liver Diseases Therapeutics Drugs Production & Consumption Trends
2.2.2 Liver Diseases Therapeutics Drugs Demand Structure Trends
2.3 Liver Diseases Therapeutics Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Oral
4.2.2 Injection
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Clinics
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Oral
5.2.2 Injection
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Oral
6.2.2 Injection
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Clinics
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Oral
7.2.2 Injection
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Clinics
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Oral
8.2.2 Injection
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Oral
9.2.2 Injection
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 F. Hoffmann-La Roche
10.1.2 Gilead Sciences
10.1.3 GlaxoSmithKline
10.1.4 Johnson & Johnson
10.1.5 Merck
10.1.6 Achillion Pharmaceuticals
10.1.7 AbbVie
10.1.8 Angion Biomedica
10.1.9 Bayer
10.1.10 LG Life Sciences
10.1.11 Phenex Pharmaceuticals
10.1.12 ProMetic Life Sciences
10.1.13 Raptor Pharmaceuticals
10.1.14 Shenzhen Kangtai Biological Products
10.1.15 Verva Pharmaceuticals
10.2 Liver Diseases Therapeutics Drugs Sales Date of Major Players (2017-2020e)
10.2.1 F. Hoffmann-La Roche
10.2.2 Gilead Sciences
10.2.3 GlaxoSmithKline
10.2.4 Johnson & Johnson
10.2.5 Merck
10.2.6 Achillion Pharmaceuticals
10.2.7 AbbVie
10.2.8 Angion Biomedica
10.2.9 Bayer
10.2.10 LG Life Sciences
10.2.11 Phenex Pharmaceuticals
10.2.12 ProMetic Life Sciences
10.2.13 Raptor Pharmaceuticals
10.2.14 Shenzhen Kangtai Biological Products
10.2.15 Verva Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Liver Diseases Therapeutics Drugs Product Type Overview
2.Table Liver Diseases Therapeutics Drugs Product Type Market Share List
3.Table Liver Diseases Therapeutics Drugs Product Type of Major Players
4.Table Brief Introduction of F. Hoffmann-La Roche
5.Table Brief Introduction of Gilead Sciences
6.Table Brief Introduction of GlaxoSmithKline
7.Table Brief Introduction of Johnson & Johnson
8.Table Brief Introduction of Merck
9.Table Brief Introduction of Achillion Pharmaceuticals
10.Table Brief Introduction of AbbVie
11.Table Brief Introduction of Angion Biomedica
12.Table Brief Introduction of Bayer
13.Table Brief Introduction of LG Life Sciences
14.Table Brief Introduction of Phenex Pharmaceuticals
15.Table Brief Introduction of ProMetic Life Sciences
16.Table Brief Introduction of Raptor Pharmaceuticals
17.Table Brief Introduction of Shenzhen Kangtai Biological Products
18.Table Brief Introduction of Verva Pharmaceuticals
19.Table Products & Services of F. Hoffmann-La Roche
20.Table Products & Services of Gilead Sciences
21.Table Products & Services of GlaxoSmithKline
22.Table Products & Services of Johnson & Johnson
23.Table Products & Services of Merck
24.Table Products & Services of Achillion Pharmaceuticals
25.Table Products & Services of AbbVie
26.Table Products & Services of Angion Biomedica
27.Table Products & Services of Bayer
28.Table Products & Services of LG Life Sciences
29.Table Products & Services of Phenex Pharmaceuticals
30.Table Products & Services of ProMetic Life Sciences
31.Table Products & Services of Raptor Pharmaceuticals
32.Table Products & Services of Shenzhen Kangtai Biological Products
33.Table Products & Services of Verva Pharmaceuticals
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global Liver Diseases Therapeutics Drugs Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global Liver Diseases Therapeutics Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global Liver Diseases Therapeutics Drugs Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global Liver Diseases Therapeutics Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
